Filing Details

Accession Number:
0001127602-13-017834
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 15:25:52
Reporting Period:
2013-05-20
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 15:25:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524338 Anthony Charles Laranjeira 65 Hayden Avenue
Lexington MA 02421
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-20 10,000 $35.90 11,257 No 4 M Direct
Common Stock Acquisiton 2013-05-20 2,500 $35.90 13,757 No 4 M Direct
Common Stock Acquisiton 2013-05-20 1,500 $42.09 15,257 No 4 M Direct
Common Stock Disposition 2013-05-20 10,000 $50.00 5,257 No 4 S Direct
Common Stock Disposition 2013-05-20 4,000 $55.00 1,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2013-05-20 10,000 $0.00 10,000 $35.90
Common Stock Stock Options (Right to Buy) Disposition 2013-05-20 2,500 $0.00 2,500 $35.90
Common Stock Stock Options (Right to Buy) Disposition 2013-05-20 1,500 $0.00 1,500 $42.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2011-10-15 2021-07-15 No 4 M Direct
37,500 2011-10-15 2021-07-15 No 4 M Direct
23,500 2012-05-16 2022-02-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 576 Indirect 401(k) Plan
Footnotes
  1. Sold pursuant to a 10(b)5-1 Plan.
  2. Option vests 6.25% quarterly over a four-year period.